Our proprietary agentic AI platform combines Large Language Models trained on billions of protein sequences with autonomous agents that plan and execute experiments 24/7.
Our foundation models are trained on over 2 billion protein sequences from UniProt, enabling unprecedented understanding of protein structure, function, and interactions. These models predict drug-target interactions with accuracy surpassing traditional molecular docking approaches.
Our agentic AI systems autonomously design multi-step experimental protocols, execute them through robotic lab automation, analyze results, and iterate—all without human intervention. This closed-loop optimization accelerates the drug discovery cycle from months to days.
Built with security-first principles for pharmaceutical and biotech partners. SOC 2 Type II certified with comprehensive data protection, encryption, and compliance frameworks for sensitive research data.
Request access to our platform and discover how agentic AI can accelerate your drug discovery pipeline.